Ferrara, Italy

Pierangelo Geppetti


 


Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Pierangelo Geppetti: Innovator in Pharmaceutical Chemistry

Introduction

Pierangelo Geppetti is a notable inventor based in Ferrara, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors involved in inflammatory diseases. With a total of 5 patents to his name, Geppetti's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents, Geppetti has developed biarylcarboxyarylamides as vanilloid-1 receptor modulators. This invention provides compounds of formula (I), wherein A and Z are defined in the description. The methods for preparing these derivatives and their application in treating inflammatory diseases, such as neuropathic pain, are also outlined. Another significant patent involves vanilloid TRPV1 receptor antagonists, which relates to compounds of formula (I) and their use in preparing pharmaceutical compositions for treating inflammatory states.

Career Highlights

Geppetti is currently associated with Pharmeste S.r.l., where he continues to innovate and develop new pharmaceutical solutions. His expertise in receptor modulation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Geppetti has collaborated with esteemed colleagues, including Pier Giovanni Baraldi and Pier Andrea Borea. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Pierangelo Geppetti's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…